United States General Anesthesia Drugs Market Report 2017

United States General Anesthesia Drugs Market Report 2017

1 General Anesthesia Drugs Overview

1.1 Product Overview and Scope of General Anesthesia Drugs

1.2 Classification of General Anesthesia Drugs by Product Category

1.2.1 United States General Anesthesia Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States General Anesthesia Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Propofol

1.2.4 Etomidate

1.2.5 Midazolam

1.2.6 Sevoflurane

1.2.7 Isoflurane

1.2.8 Other

1.3 United States General Anesthesia Drugs Market by Application/End Users

1.3.1 United States General Anesthesia Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Intravenous Anesthetics

1.3.3 Inhalational Anesthetics

1.4 United States General Anesthesia Drugs Market by Region

1.4.1 United States General Anesthesia Drugs Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West General Anesthesia Drugs Status and Prospect (2012-2022)

1.4.3 Southwest General Anesthesia Drugs Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic General Anesthesia Drugs Status and Prospect (2012-2022)

1.4.5 New England General Anesthesia Drugs Status and Prospect (2012-2022)

1.4.6 The South General Anesthesia Drugs Status and Prospect (2012-2022)

1.4.7 The Midwest General Anesthesia Drugs Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of General Anesthesia Drugs (2012-2022)

1.5.1 United States General Anesthesia Drugs Sales and Growth Rate (2012-2022)

1.5.2 United States General Anesthesia Drugs Revenue and Growth Rate (2012-2022)

2 United States General Anesthesia Drugs Market Competition by Players/Suppliers

2.1 United States General Anesthesia Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States General Anesthesia Drugs Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States General Anesthesia Drugs Average Price by Players/Suppliers (2012-2017)

2.4 United States General Anesthesia Drugs Market Competitive Situation and Trends

2.4.1 United States General Anesthesia Drugs Market Concentration Rate

2.4.2 United States General Anesthesia Drugs Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers General Anesthesia Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States General Anesthesia Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States General Anesthesia Drugs Sales and Market Share by Region (2012-2017)

3.2 United States General Anesthesia Drugs Revenue and Market Share by Region (2012-2017)

3.3 United States General Anesthesia Drugs Price by Region (2012-2017)

4 United States General Anesthesia Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States General Anesthesia Drugs Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States General Anesthesia Drugs Revenue and Market Share by Type (2012-2017)

4.3 United States General Anesthesia Drugs Price by Type (2012-2017)

4.4 United States General Anesthesia Drugs Sales Growth Rate by Type (2012-2017)

5 United States General Anesthesia Drugs Sales (Volume) by Application (2012-2017)

5.1 United States General Anesthesia Drugs Sales and Market Share by Application (2012-2017)

5.2 United States General Anesthesia Drugs Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States General Anesthesia Drugs Players/Suppliers Profiles and Sales Data

6.1 Astrazeneca

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 General Anesthesia Drugs Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Astrazeneca General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Fresenius-Kabi

6.2.2 General Anesthesia Drugs Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 AbbVie

6.3.2 General Anesthesia Drugs Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 AbbVie General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Baxter Healthcare

6.4.2 General Anesthesia Drugs Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 B.Braun

6.5.2 General Anesthesia Drugs Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 B.Braun General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Maruishi

6.6.2 General Anesthesia Drugs Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Maruishi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Piramal

6.7.2 General Anesthesia Drugs Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Piramal General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Hikma Pharmaceuticals

6.8.2 General Anesthesia Drugs Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Mylan

6.9.2 General Anesthesia Drugs Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Mylan General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Nhwa

6.10.2 General Anesthesia Drugs Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Nhwa General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Hengrui

6.12 Lunan

7 General Anesthesia Drugs Manufacturing Cost Analysis

7.1 General Anesthesia Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of General Anesthesia Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 General Anesthesia Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of General Anesthesia Drugs Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States General Anesthesia Drugs Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States General Anesthesia Drugs Sales Volume, Revenue Forecast (2017-2022)

11.2 United States General Anesthesia Drugs Sales Volume Forecast by Type (2017-2022)

11.3 United States General Anesthesia Drugs Sales Volume Forecast by Application (2017-2022)

11.4 United States General Anesthesia Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of General Anesthesia Drugs

Figure United States General Anesthesia Drugs Market Size (K L) by Type (2012-2022)

Figure United States General Anesthesia Drugs Sales Volume Market Share by Type (Product Category) in 2016

Figure Propofol Product Picture

Figure Etomidate Product Picture

Figure Midazolam Product Picture

Figure Sevoflurane Product Picture

Figure Isoflurane Product Picture

Figure Other Product Picture

Figure United States General Anesthesia Drugs Market Size (K L) by Application (2012-2022)

Figure United States Sales Market Share of General Anesthesia Drugs by Application in 2016

Figure Intravenous Anesthetics Examples

Table Key Downstream Customer in Intravenous Anesthetics

Figure Inhalational Anesthetics Examples

Table Key Downstream Customer in Inhalational Anesthetics

Figure United States General Anesthesia Drugs Market Size (Million USD) by Region (2012-2022)

Figure The West General Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest General Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic General Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England General Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US General Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest General Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States General Anesthesia Drugs Sales (K L) and Growth Rate (2012-2022)

Figure United States General Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States General Anesthesia Drugs Market Major Players Product Sales Volume (K L) (2012-2017)

Table United States General Anesthesia Drugs Sales (K L) of Key Players/Suppliers (2012-2017)

Table United States General Anesthesia Drugs Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States General Anesthesia Drugs Sales Share by Players/Suppliers

Figure 2017 United States General Anesthesia Drugs Sales Share by Players/Suppliers

Figure United States General Anesthesia Drugs Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States General Anesthesia Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States General Anesthesia Drugs Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States General Anesthesia Drugs Revenue Share by Players/Suppliers

Figure 2017 United States General Anesthesia Drugs Revenue Share by Players/Suppliers

Table United States Market General Anesthesia Drugs Average Price (USD/L) of Key Players/Suppliers (2012-2017)

Figure United States Market General Anesthesia Drugs Average Price (USD/L) of Key Players/Suppliers in 2016

Figure United States General Anesthesia Drugs Market Share of Top 3 Players/Suppliers

Figure United States General Anesthesia Drugs Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers General Anesthesia Drugs Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers General Anesthesia Drugs Product Category

Table United States General Anesthesia Drugs Sales (K L) by Region (2012-2017)

Table United States General Anesthesia Drugs Sales Share by Region (2012-2017)

Figure United States General Anesthesia Drugs Sales Share by Region (2012-2017)

Figure United States General Anesthesia Drugs Sales Market Share by Region in 2016

Table United States General Anesthesia Drugs Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States General Anesthesia Drugs Revenue Share by Region (2012-2017)

Figure United States General Anesthesia Drugs Revenue Market Share by Region (2012-2017)

Figure United States General Anesthesia Drugs Revenue Market Share by Region in 2016

Table United States General Anesthesia Drugs Price (USD/L) by Region (2012-2017)

Table United States General Anesthesia Drugs Sales (K L) by Type (2012-2017)

Table United States General Anesthesia Drugs Sales Share by Type (2012-2017)

Figure United States General Anesthesia Drugs Sales Share by Type (2012-2017)

Figure United States General Anesthesia Drugs Sales Market Share by Type in 2016

Table United States General Anesthesia Drugs Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States General Anesthesia Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of General Anesthesia Drugs by Type (2012-2017)

Figure Revenue Market Share of General Anesthesia Drugs by Type in 2016

Table United States General Anesthesia Drugs Price (USD/L) by Types (2012-2017)

Figure United States General Anesthesia Drugs Sales Growth Rate by Type (2012-2017)

Table United States General Anesthesia Drugs Sales (K L) by Application (2012-2017)

Table United States General Anesthesia Drugs Sales Market Share by Application (2012-2017)

Figure United States General Anesthesia Drugs Sales Market Share by Application (2012-2017)

Figure United States General Anesthesia Drugs Sales Market Share by Application in 2016

Table United States General Anesthesia Drugs Sales Growth Rate by Application (2012-2017)

Figure United States General Anesthesia Drugs Sales Growth Rate by Application (2012-2017)

Table Astrazeneca Basic Information List

Table Astrazeneca General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2012-2017)

Figure Astrazeneca General Anesthesia Drugs Sales Growth Rate (2012-2017)

Figure Astrazeneca General Anesthesia Drugs Sales Market Share in United States (2012-2017)

Figure Astrazeneca General Anesthesia Drugs Revenue Market Share in United States (2012-2017)

Table Fresenius-Kabi Basic Information List

Table Fresenius-Kabi General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2012-2017)

Figure Fresenius-Kabi General Anesthesia Drugs Sales Growth Rate (2012-2017)

Figure Fresenius-Kabi General Anesthesia Drugs Sales Market Share in United States (2012-2017)

Figure Fresenius-Kabi General Anesthesia Drugs Revenue Market Share in United States (2012-2017)

Table AbbVie Basic Information List

Table AbbVie General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2012-2017)

Figure AbbVie General Anesthesia Drugs Sales Growth Rate (2012-2017)

Figure AbbVie General Anesthesia Drugs Sales Market Share in United States (2012-2017)

Figure AbbVie General Anesthesia Drugs Revenue Market Share in United States (2012-2017)

Table Baxter Healthcare Basic Information List

Table Baxter Healthcare General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2012-2017)

Figure Baxter Healthcare General Anesthesia Drugs Sales Growth Rate (2012-2017)

Figure Baxter Healthcare General Anesthesia Drugs Sales Market Share in United States (2012-2017)

Figure Baxter Healthcare General Anesthesia Drugs Revenue Market Share in United States (2012-2017)

Table B.Braun Basic Information List

Table B.Braun General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2012-2017)

Figure B.Braun General Anesthesia Drugs Sales Growth Rate (2012-2017)

Figure B.Braun General Anesthesia Drugs Sales Market Share in United States (2012-2017)

Figure B.Braun General Anesthesia Drugs Revenue Market Share in United States (2012-2017)

Table Maruishi Basic Information List

Table Maruishi General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2012-2017)

Figure Maruishi General Anesthesia Drugs Sales Growth Rate (2012-2017)

Figure Maruishi General Anesthesia Drugs Sales Market Share in United States (2012-2017)

Figure Maruishi General Anesthesia Drugs Revenue Market Share in United States (2012-2017)

Table Piramal Basic Information List

Table Piramal General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2012-2017)

Figure Piramal General Anesthesia Drugs Sales Growth Rate (2012-2017)

Figure Piramal General Anesthesia Drugs Sales Market Share in United States (2012-2017)

Figure Piramal General Anesthesia Drugs Revenue Market Share in United States (2012-2017)

Table Hikma Pharmaceuticals Basic Information List

Table Hikma Pharmaceuticals General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2012-2017)

Figure Hikma Pharmaceuticals General Anesthesia Drugs Sales Growth Rate (2012-2017)

Figure Hikma Pharmaceuticals General Anesthesia Drugs Sales Market Share in United States (2012-2017)

Figure Hikma Pharmaceuticals General Anesthesia Drugs Revenue Market Share in United States (2012-2017)

Table Mylan Basic Information List

Table Mylan General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2012-2017)

Figure Mylan General Anesthesia Drugs Sales Growth Rate (2012-2017)

Figure Mylan General Anesthesia Drugs Sales Market Share in United States (2012-2017)

Figure Mylan General Anesthesia Drugs Revenue Market Share in United States (2012-2017)

Table Nhwa Basic Information List

Table Nhwa General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2012-2017)

Figure Nhwa General Anesthesia Drugs Sales Growth Rate (2012-2017)

Figure Nhwa General Anesthesia Drugs Sales Market Share in United States (2012-2017)

Figure Nhwa General Anesthesia Drugs Revenue Market Share in United States (2012-2017)

Table Hengrui Basic Information List

Table Lunan Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of General Anesthesia Drugs

Figure Manufacturing Process Analysis of General Anesthesia Drugs

Figure General Anesthesia Drugs Industrial Chain Analysis

Table Raw Materials Sources of General Anesthesia Drugs Major Players/Suppliers in 2016

Table Major Buyers of General Anesthesia Drugs

Table Distributors/Traders List

Figure United States General Anesthesia Drugs Sales Volume (K L) and Growth Rate Forecast (2017-2022)

Figure United States General Anesthesia Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States General Anesthesia Drugs Price (USD/L) Trend Forecast (2017-2022)

Table United States General Anesthesia Drugs Sales Volume (K L) Forecast by Type (2017-2022)

Figure United States General Anesthesia Drugs Sales Volume (K L) Forecast by Type (2017-2022)

Figure United States General Anesthesia Drugs Sales Volume (K L) Forecast by Type in 2022

Table United States General Anesthesia Drugs Sales Volume (K L) Forecast by Application (2017-2022)

Figure United States General Anesthesia Drugs Sales Volume (K L) Forecast by Application (2017-2022)

Figure United States General Anesthesia Drugs Sales Volume (K L) Forecast by Application in 2022

Table United States General Anesthesia Drugs Sales Volume (K L) Forecast by Region (2017-2022)

Table United States General Anesthesia Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States General Anesthesia Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States General Anesthesia Drugs Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources